RadNet has acquired ultrasound AI vendor See-Mode Technologies, aiming to enhance workflow efficiency and expand its imaging AI offerings.
Key Details
- 1RadNet completed the acquisition of See-Mode Technologies, an AI company focused on breast and thyroid ultrasound analysis.
- 2See-Mode's FDA-cleared thyroid solution is already deployed at some RadNet outpatient centers, showing a 30% reduction in scan times.
- 3Approximately 20 million ultrasound exams for thyroid and breast are performed annually in the US, highlighting a large addressable market.
- 4RadNet plans to integrate See-Mode’s products into its DeepHealth AI portfolio and market them to third parties.
- 5The deal follows earlier acquisitions of iCAD, Quantib, Aidence, and Kheiron by RadNet, further bolstering their AI division.
- 6Financial terms of the acquisition were not disclosed.
Why It Matters
This acquisition demonstrates RadNet's commitment to expanding AI-driven workflow improvements in high-volume, complex ultrasound exams, potentially increasing access and efficiency. The integration of advanced AI solutions is positioned to benefit both clinicians and patients, with commercial implications for the broader radiology AI market.
Source
Radiology Business
Related News
•AI in Healthcare
Nvidia, Amazon Drive AI Expansion Across Genomics and Radiology
Major healthcare and technology companies partner to push AI advancements in genomics, radiology, and broader healthcare.
•HealthExec
AI Drives Advances in Radiology, Genomics, and Healthcare Policy
Recent developments highlight AI's expanding role in radiology, genomics, and healthcare infrastructure.
•Radiology Business
Nvidia CEO Highlights AI’s Expanding Impact on Radiology Careers
Nvidia CEO Jensen Huang says AI is making radiologists more essential, not obsolete.